A bioengineered artificial interstitium supports long-term islet xenograft survival in nonhuman primates without immunosuppression
Science Advances · 2024
DOI: 10.1126/sciadv.adi4919 ↗Kurz gefasst
Fachartikel in der Zeitschrift Science Advances, 2024. Verfasst von Scott H Oppler und 13 weiteren Autor:innen. Beteiligte Einrichtung: Department of Surgery, University of Minnesota, Minneapolis, MN, USA. Hauptthemen laut MEDLINE: Immunosuppression Therapy, Primates. Die Arbeit wurde bisher 12-mal zitiert (Crossref) und nennt 108 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NIDDK NIH HHS.
Abstract (Originalsprache)
Cell-based therapies hold promise for many chronic conditions; however, the continued need for immunosuppression along with challenges in replacing cells to improve durability or retrieving cells for safety are major obstacles. We subcutaneously implanted a device engineered to exploit the innate transcapillary hydrostatic and colloid osmotic pressure generating ultrafiltrate to mimic interstitium. Long-term stable accumulation of ultrafiltrate was achieved in both rodents and nonhuman primates (NHPs) that was chemically similar to serum and achieved capillary blood oxygen concentration. The majority of adult pig islet grafts transplanted in non-immunosuppressed NHPs resulted in xenograft survival >100 days. Stable cytokine levels, normal neutrophil to lymphocyte ratio, and a lack of immune cell infiltration demonstrated successful immunoprotection and averted typical systemic changes related to xenograft transplant, especially inflammation. This approach eliminates the need for immunosuppression and permits percutaneous access for loading, reloading, biopsy, and recovery to de-risk the use of “unlimited” xenogeneic cell sources to realize widespread clinical translation of cell-based therapies.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Autor:innen und Institutionen
- Department of Surgery, University of Minnesota, Minneapolis, MN, USA.
- Department of Veterinary Clinical Sciences, College of Veterinary Medicine, University of Minnesota, St. Paul, MN, USA.
- Department of Internal Medicine, University of Central Florida College of Medicine, Orlando, FL, USA.
- Department of Veterinary Population Medicine, University of Minnesota, St. Paul, MN, USA.
- Cell-Safe LifeSciences, Skokie, IL, USA.
- Medline UNITE Foot and Ankle, Medline Industries LP, 3 Lakes Drive, Northfield, IL, USA.
ORCID-Profile: Scott H Oppler, Laura L Hocum Stone, David J Leishman, Jody L Janecek, Meghan E G Moore, Parthasarathy Rangarajan, Bradley J Willenberg, Timothy D O'Brien, Jaime Modiano, Sabarinathan Ramachandran, Melanie L Graham
Förderung
- NIDDK NIH HHS
Zitieren
APA
Oppler, S. H., Hocum Stone, L. L., Leishman, D. J., Janecek, J. L., Moore, M. E. G., Rangarajan, P., Willenberg, B. J., O'Brien, T. D., Modiano, J., Pheil, N., Dalton, J., Dalton, M., Ramachandran, S., & Graham, M. L. (2024). A bioengineered artificial interstitium supports long-term islet xenograft survival in nonhuman primates without immunosuppression. Science Advances. https://doi.org/10.1126/sciadv.adi4919
Vancouver
Oppler SH, Hocum Stone LL, Leishman DJ, Janecek JL, Moore MEG, Rangarajan P, et al. A bioengineered artificial interstitium supports long-term islet xenograft survival in nonhuman primates without immunosuppression. Science Advances. 2024. doi:10.1126/sciadv.adi4919
BibTeX
@article{Oppler2024,
author = {Oppler, Scott H and Hocum Stone, Laura L and Leishman, David J and Janecek, Jody L and Moore, Meghan E G and Rangarajan, Parthasarathy and Willenberg, Bradley J and O'Brien, Timothy D and Modiano, Jaime and Pheil, Natan and Dalton, Jordan and Dalton, Michael and Ramachandran, Sabarinathan and Graham, Melanie L},
title = {A bioengineered artificial interstitium supports long-term islet xenograft survival in nonhuman primates without immunosuppression},
journal = {Science Advances},
year = {2024},
doi = {10.1126/sciadv.adi4919}
}
EUVIMED